Status:

COMPLETED

Phosphate Kinetic Modeling 2

Lead Sponsor:

Fresenius Medical Care North America

Collaborating Sponsors:

Renal Research Institute

Conditions:

Hyperphosphatemia

ESRD

Eligibility:

All Genders

18+ years

Phase:

PHASE4

Brief Summary

The study aims to investigate the concept of computer based Phosphate Kinetic Modeling (PKM) in the hemodialysis patient population. This computerized algorithm model was developed as a tool to aid ph...

Detailed Description

PKM consists of a set of validated and computerized algorithms to perform the following steps: 1. Calculate calcium (Ca) and phosphorus (P) intake and absorption in individual patients as a function ...

Eligibility Criteria

Inclusion

  • Subject is capable of giving informed consent.
  • Age \> 18 years
  • Thrice weekly hemodialysis with a dialysate Ca++ concentration (CdiCa) of 2.0, 2.25 or 2.5 mEq/L
  • Stable CdiCa of either 2.0, 2.25 or 2.5 mEq/L for ≥ 4 weeks
  • Dialysis vintage ≥ 3 months
  • Three-month average P \> 5.5 mg/dL AND 2 of 3 monthly average P \>=5.8 mg/dL
  • Patients currently prescribed calcium acetate (PhosLo) mono-therapy , sevelamer monotherapy, or a combination therapy of PhosLo plus sevelamer for phosphate binding with willingness of physician to switch to PhosLo monotherapy
  • Fresenius Optiflux F 160, 180 or 200 dialyzer

Exclusion

  • Any laboratory abnormality, medical condition or psychiatric disorder which in the opinion of the investigator would put the subject's disease management at risk or may result in the subject being unable to comply with study requirements
  • Known pregnancy
  • Parathyroidectomy
  • iPTH \< 50 pg/mL
  • Hospitalization in past 30 days
  • Dialysate potassium prescription other than 2 or 3 mmol/L
  • Serum Ca++ \< 7.5 mg/dL
  • Current vitamin D therapy using calcitriol

Key Trial Info

Start Date :

September 1 2010

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

December 1 2011

Estimated Enrollment :

81 Patients enrolled

Trial Details

Trial ID

NCT01252771

Start Date

September 1 2010

End Date

December 1 2011

Last Update

August 18 2014

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Renal Research Insitutue

New York, New York, United States, 10128